Centers for Disease Control and Prevention

Aflac reimagines term life insurance to help close the financial security gap for more Americans

Retrieved on: 
Tuesday, July 25, 2023

COLUMBUS, Ga., July 25, 2023 /PRNewswire/ -- Chronic diseases are the leading causes of illness, disability and death in the U.S., according to the Centers for Disease Control and Prevention.1 Addressing the need for better options for Life Insurance, Aflac, a leading provider of supplemental health insurance products in the U.S., announced today the launch of a new product, Aflac Group Life Term to 120, to provide worksite life insurance with flexible living benefits and affordable rates that won't increase across employees' lifespans. 

Key Points: 
  • "Aflac's Term Life to 120 product is designed so that it is easy to use whenever it's needed.
  • Aflac Group Term to 120 offers more than the typical life insurance with:
    Hybrid plan design that merges the most attractive features of a term life plan and a permanent life plan to give consumers what they value most.
  • Extension of chronic conditions periodic payment rider adds an additional 25 monthly payments, equal to 4% of the life insurance benefit amount for chronic conditions.
  • *Aflac's Group Term to 120 product defines a lifetime as up to 120 years of age to guarantee individuals do not outlive their coverage.

New Studies Show Daily Prune Consumption Supports Cardiovascular Health in Aging Population

Retrieved on: 
Monday, July 24, 2023

"We want to advance the research on this topic area to better understand how prune consumption relates to cardiometabolic health outcomes, especially in the aging population that often experiences an elevated risk for cardiovascular disease."

Key Points: 
  • "We want to advance the research on this topic area to better understand how prune consumption relates to cardiometabolic health outcomes, especially in the aging population that often experiences an elevated risk for cardiovascular disease."
  • "It is exciting to see research on prune consumption and cardiovascular health expand," says Andrea N. Giancoli, MPH, RDN, Nutrition Advisor, California Prune Board.
  • These two studies represent the latest additions of research on prune consumption and human health.
  • Previous research has shown that daily prune consumption can help support gut health, bone health, and weight management.

American College of Lifestyle Medicine Applauds U.S. Mayors for Recently Adopted Resolution on Plant-Based Approach to Chronic Disease, Climate, Fiscal Sustainability

Retrieved on: 
Wednesday, July 19, 2023

ST. LOUIS, July 19, 2023 /PRNewswire/ -- The American College of Lifestyle Medicine (ACLM) applauds a resolution recently ratified by the U.S. Conference of Mayors supporting a plant-based approach to combat chronic disease, help mitigate the climate crisis and create a more sustainable fiscal trajectory.

Key Points: 
  • ST. LOUIS, July 19, 2023 /PRNewswire/ -- The American College of Lifestyle Medicine (ACLM) applauds a resolution recently ratified by the U.S. Conference of Mayors supporting a plant-based approach to combat chronic disease, help mitigate the climate crisis and create a more sustainable fiscal trajectory.
  • The resolution also notes that a primary driver of climate change is the food we grow, promote, and consume on a daily basis.
  • The United States Conference of Mayors is the official non-partisan organization of cities with populations of 30,000 or more.
  • Each city is represented in the Conference by its chief elected official, the mayor.

HealthspanMD™ Launches Reverse AFib Program to Help Greater Phoenix Residents Treat and Manage the Potentially Deadly Condition

Retrieved on: 
Tuesday, July 18, 2023

With deaths from AFib increasing steadily over the past two decades, more than 12 million Americans are expected to have AFib by 2030.

Key Points: 
  • With deaths from AFib increasing steadily over the past two decades, more than 12 million Americans are expected to have AFib by 2030.
  • “AFib is complex and challenging to treat,” said HealthspanMD Founder and board-certified cardiologist Robert Todd Hurst, MD, FACC, FASE.
  • However, Phoenix-based HealthspanMD has elevated these conventional treatments by introducing its Reverse AFib Program .
  • Enrollment in an ongoing, connected program with a team of experts to optimize the chance of reversing AFib.

CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season

Retrieved on: 
Monday, July 17, 2023

CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older.

Key Points: 
  • CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older.
  • CSL Seqirus is the only manufacturer to offer differentiated influenza vaccine options approved for use in individuals six months of age and older.
  • This year's 2023/24 U.S. influenza season portfolio includes:
    There were two real world evidence (RWE) studies conducted by the Marshfield Clinic Research Institute during the 2022/23 Northern Hemisphere season, in which a large majority (84%) of vaccinated participants received FLUCELVAX QUADRIVALENT.
  • For additional information on influenza vaccine options for the upcoming flu season, visit flu360.com.

Using Doxy to Prevent STIs Warrants Caution

Retrieved on: 
Wednesday, July 12, 2023

“We ignore the risk of rising antibiotic resistance at great peril to global public health,” said Michael Weinstein, AHF’s president and cofounder.

Key Points: 
  • “We ignore the risk of rising antibiotic resistance at great peril to global public health,” said Michael Weinstein, AHF’s president and cofounder.
  • “We already are facing perilous drug resistance for gonorrhea treatments.
  • Condoms remain the most effective means of preventing STIs.”
    [1] National Institutes of Health.
  • To learn more about AHF, please visit our website , find us on Facebook , follow us on IG and Twitter , or subscribe to our “AHFter Hours” podcast.

Novavax's Nuvaxovid™ Receives Full Marketing Authorization in the EU for the Prevention of COVID

Retrieved on: 
Thursday, July 6, 2023

Monitor the Novavax COVID-19 Vaccine, Adjuvanted recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control (CDC) and Prevention guidelines .

Key Points: 
  • Monitor the Novavax COVID-19 Vaccine, Adjuvanted recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control (CDC) and Prevention guidelines .
  • Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Novavax COVID-19 Vaccine, Adjuvanted.
  • Myocarditis, pericarditis, anaphylaxis, paresthesia, and hypoesthesia have been reported following administration of the Novavax COVID-19 Vaccine, Adjuvanted outside of clinical trials.
  • The reports should include the words "Novavax COVID-19 Vaccine, Adjuvanted EUA" in the description section of the report.

Novavax's Nuvaxovid™ Receives Full Marketing Authorization in the EU for the Prevention of COVID

Retrieved on: 
Thursday, July 6, 2023

Monitor the Novavax COVID-19 Vaccine, Adjuvanted recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control (CDC) and Prevention guidelines .

Key Points: 
  • Monitor the Novavax COVID-19 Vaccine, Adjuvanted recipients for the occurrence of immediate adverse reactions according to the Centers for Disease Control (CDC) and Prevention guidelines .
  • Altered Immunocompetence: Immunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Novavax COVID-19 Vaccine, Adjuvanted.
  • Myocarditis, pericarditis, anaphylaxis, paresthesia, and hypoesthesia have been reported following administration of the Novavax COVID-19 Vaccine, Adjuvanted outside of clinical trials.
  • The reports should include the words "Novavax COVID-19 Vaccine, Adjuvanted EUA" in the description section of the report.

Solectrac achieves significant expansion of its certified dealership network, increasing access to its pioneering electric tractors across the United States

Retrieved on: 
Thursday, July 6, 2023

During the second quarter of 2023, Solectrac added 10 certified dealerships with 18 locations in Tennessee, Kansas, Maine, Nebraska, Illinois, Texas and Florida.

Key Points: 
  • During the second quarter of 2023, Solectrac added 10 certified dealerships with 18 locations in Tennessee, Kansas, Maine, Nebraska, Illinois, Texas and Florida.
  • "Dealerships are where customers often get their first experience with one of our quiet, clean, and powerful electric tractors," said Mani Iyer, CEO of Solectrac.
  • Recently, Solectrac announced that it is collaborating with its certified dealerships on an electric tractor rental program , allowing customers to experience the benefits of Solectrac electric tractors on a monthly basis.
  • Solectrac is a subsidiary of Ideanomics (Nasdaq: IDEX), a global company with the mission to accelerate the adoption of electric vehicles.

United States Tobacco Markets Report 2023: Demand for Premium Cigars Having a Positive Impact on the Near $100 Billion Industry

Retrieved on: 
Thursday, July 6, 2023

There are a number of elements that influence the tobacco market in the United States, including addiction, marketing and advertising, societal and economic concerns, and globalization.

Key Points: 
  • There are a number of elements that influence the tobacco market in the United States, including addiction, marketing and advertising, societal and economic concerns, and globalization.
  • The industry has also made significant investments in marketing and advertising to promote tobacco usage and smoking.
  • Due to growing consumer awareness of the negative effects of tobacco use, the demand for tobacco in the United States is predicted to be low.
  • Company Profiles: Detailed analysis of the major companies present in the United States tobacco market.